Shahrokh F. Shariat, M.D.
Shahrokh F. Shariat, M.D.
Department of Urology, Comprehensive Cancer Center, Medical University of Vienna and General
Adresse e-mail validée de - Page d'accueil
Citée par
Citée par
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
AC Wolff, MEH Hammond, JN Schwartz, KL Hagerty, DC Allred, RJ Cote, ...
Archives of pathology & laboratory medicine 131 (1), 18-43, 2007
Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer: a multi-institutional update
AW Partin, MW Kattan, ENP Subong, PC Walsh, KJ Wojno, JE Oesterling, ...
Jama 277 (18), 1445-1451, 1997
The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia
JD McConnell, CG Roehrborn, OM Bautista, GL Andriole Jr, CM Dixon, ...
New England Journal of Medicine 349 (25), 2387-2398, 2003
Elastic moduli of breast and prostate tissues under compression
TA Krouskop, TM Wheeler, F Kallel, BS Garra, T Hall
Ultrasonic imaging 20 (4), 260-274, 1998
Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men
WJ Catalona, JP Richie, FR Ahmann, MLA Hudson, PT Scardino, ...
The Journal of urology 151 (5), 1283-1290, 1994
Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study
WC Huang, AS Levey, AM Serio, M Snyder, AJ Vickers, GV Raj, ...
The lancet oncology 7 (9), 735-740, 2006
Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial
WJ Catalona, AW Partin, KM Slawin, MK Brawer, RC Flanigan, A Patel, ...
Jama 279 (19), 1542-1547, 1998
Epidemiology and risk factors of urothelial bladder cancer
M Burger, JWF Catto, G Dalbagni, HB Grossman, H Herr, P Karakiewicz, ...
European urology 63 (2), 234-241, 2013
A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer
MW Kattan, JA Eastham, AMF Stapleton, TM Wheeler, PT Scardino
JNCI: Journal of the National Cancer Institute 90 (10), 766-771, 1998
Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors
IS Gill, LR Kavoussi, BR Lane, ML Blute, D Babineau, JR Colombo, ...
The Journal of urology 178 (1), 41-46, 2007
EAU guidelines on non–muscle-invasive urothelial carcinoma of the bladder: update 2013
M Babjuk, M Burger, R Zigeuner, SF Shariat, BWG Van Rhijn, E Compérat, ...
European urology 64 (4), 639-653, 2013
EAU guidelines on non–muscle-invasive urothelial carcinoma of the bladder: update 2016
M Babjuk, A Böhle, M Burger, O Capoun, D Cohen, EM Compérat, ...
European urology 71 (3), 447-461, 2017
Cancer control with radical prostatectomy alone in 1,000 consecutive patients
GW Hull, F Rabbani, F Abbas, TM Wheeler, MW Kattan, PT Scardino
The Journal of urology 167 (2 Part 1), 528-534, 2002
Variations in morbidity after radical prostatectomy
CB Begg, ER Riedel, PB Bach, MW Kattan, D Schrag, JL Warren, ...
New England Journal of Medicine 346 (15), 1138-1144, 2002
Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer
MW Kattan, TM Wheeler, PT Scardino
Journal of clinical oncology 17 (5), 1499-1499, 1999
A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy
KJ Van Zee, DME Manasseh, JLB Bevilacqua, SK Boolbol, JV Fey, ...
Annals of surgical oncology 10 (10), 1140-1151, 2003
EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder
M Babjuk, W Oosterlinck, R Sylvester, E Kaasinen, A Böhle, ...
European urology 54 (2), 303-314, 2008
A postoperative prognostic nomogram for renal cell carcinoma
The Journal of urology 166 (1), 63-67, 2001
Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration
V Margulis, SF Shariat, SF Matin, AM Kamat, R Zigeuner, E Kikuchi, ...
Cancer 115 (6), 1224-1233, 2009
Prognostic model for predicting survival in men with hormone-refractory metastatic prostate cancer
S Halabi, EJ Small, PW Kantoff, MW Kattan, EB Kaplan, NA Dawson, ...
Journal of Clinical Oncology 21 (7), 1232-1237, 2003
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20